{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T16:08:02Z","timestamp":1783440482773,"version":"3.54.6"},"reference-count":42,"publisher":"Wiley","issue":"7","license":[{"start":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["movementdisorders.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Movement Disorders"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Calcitriol, the active form of vitamin D (also known as 1,25\u2010dihydroxycholecalciferol), improves the phenotype and increases frataxin levels in cell models of Friedreich ataxia (FRDA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Based on these results, we aimed measuring the effects of a calcitriol dose of 0.25 mcg\/24h in the neurological function and frataxin levels when administered to FRDA patients for a year.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>20 FRDA patients where recluted and 15 patients completed the treatment for a year. Evaluations of neurological function changes (SARA scale, 9\u2010HPT, 8\u2010MWT, PATA test) and quality of life (Barthel Scale and Short Form (36) Health Survey [SF\u201036] quality of life questionnaire) were performed. Frataxin amounts were measured in isolated platelets obtained from these FRDA patients, from heterozygous FRDA carriers (relatives of the FA patients) and from non\u2010heterozygous sex and age matched controls.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Although the patients did not experience any observable neurological improvement, there was a statistically significant increase in frataxin levels from initial values, 5.5 to 7.0\u2009pg\/\u03bcg after 12\u2009months. Differences in frataxin levels referred to total protein levels were observed among sex\u2010 and age\u2010matched controls (18.1 pg\/\u03bcg), relative controls (10.1\u2009pg\/\u03bcg), and FRDA patients (5.7\u2009pg\/\u03bcg). The treatment was well tolerated by most patients, and only some of them experienced minor adverse effects at the beginning of the trial.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Calcitriol dosage used (0.25\u2009mcg\/24\u2009h) is safe for FRDA patients, and it increases frataxin levels. We cannot rule out that higher doses administered longer could yield neurological benefits. \u00a9 2024 The Authors.\n                      <jats:italic>Movement Disorders<\/jats:italic>\n                      published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/mds.29808","type":"journal-article","created":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T12:34:02Z","timestamp":1714653242000},"page":"1099-1108","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Calcitriol Treatment Is Safe and Increases Frataxin Levels in Friedreich Ataxia Patients"],"prefix":"10.1002","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9045-190X","authenticated-orcid":false,"given":"Berta","family":"Alemany\u2010Perna","sequence":"first","affiliation":[{"name":"Ataxia Unit, Neurology Service ICS\/IAS, Hospital Josep Trueta\/Hospital Santa Caterina  Girona\/Salt Spain"},{"name":"Department of Medical Sciences University of Girona (UdG)  Girona Spain"},{"name":"Neurodegeneration and Neuroinflammacion Group Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI)  Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Tamarit","sequence":"additional","affiliation":[{"name":"Departament de Ci\u00e8ncies M\u00e8diques B\u00e0siques Institut de Recerca Biom\u00e8dica de Lleida (IRBLleida), Universitat de Lleida  Lleida Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Cabiscol","sequence":"additional","affiliation":[{"name":"Departament de Ci\u00e8ncies M\u00e8diques B\u00e0siques Institut de Recerca Biom\u00e8dica de Lleida (IRBLleida), Universitat de Lleida  Lleida Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabien","family":"Delaspre","sequence":"additional","affiliation":[{"name":"Departament de Ci\u00e8ncies M\u00e8diques B\u00e0siques Institut de Recerca Biom\u00e8dica de Lleida (IRBLleida), Universitat de Lleida  Lleida Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Miguela","sequence":"additional","affiliation":[{"name":"Neurodegeneration and Neuroinflammacion Group Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI)  Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana Maria","family":"Huertas\u2010Pons","sequence":"additional","affiliation":[{"name":"Neurodegeneration and Neuroinflammacion Group Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI)  Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Quiroga\u2010Varela","sequence":"additional","affiliation":[{"name":"Neurodegeneration and Neuroinflammacion Group Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI)  Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Merchan Ruiz","sequence":"additional","affiliation":[{"name":"Neurodegeneration and Neuroinflammacion Group Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI)  Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"L\u00f3pez Dom\u00ednguez","sequence":"additional","affiliation":[{"name":"Ataxia Unit, Neurology Service ICS\/IAS, Hospital Josep Trueta\/Hospital Santa Caterina  Girona\/Salt Spain"},{"name":"Department of Medical Sciences University of Girona (UdG)  Girona Spain"},{"name":"Neurodegeneration and Neuroinflammacion Group Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI)  Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Llu\u00eds","family":"Rami\u00f3 i Torrent\u00e0","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences University of Girona (UdG)  Girona Spain"},{"name":"Neurology Service, ICS\/IAS, Hospital Josep Trueta\/Hospital Santa Caterina, Girona\/Salt, Neurodegeneration and Neuroinflammacion Group (IDIBGI)  Girona\/Salt Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gen\u00eds","sequence":"additional","affiliation":[{"name":"Neurodegeneration and Neuroinflammacion Group Institut d'Investigaci\u00f3 Biom\u00e8dica de Girona (IDIBGI)  Girona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Ros","sequence":"additional","affiliation":[{"name":"Departament de Ci\u00e8ncies M\u00e8diques B\u00e0siques Institut de Recerca Biom\u00e8dica de Lleida (IRBLleida), Universitat de Lleida  Lleida Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,5,2]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.271.5254.1423"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.1162"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24595"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/104.3.589"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/jnc.12317"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199610173351601"},{"issue":"3","key":"e_1_2_11_9_1","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla A","year":"1996","journal-title":"Am J Hum Genet"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1579"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C400107200"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(01)00357-1"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2015.01.008"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.5.1863"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(17)33338-0"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1019441108"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2015.0434"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpt160"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.09.117"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuint.2009.03.010"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2011.01.021"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/15701611113119990021"},{"key":"e_1_2_11_23_1","doi-asserted-by":"publisher","DOI":"10.1042\/BCJ20200331"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2013.53"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/9781118874905"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1177\/0962280215588241"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780132309"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.4780141709"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.134221"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.7b04590"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)30287-3"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(21)00027-2"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21177"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60382-2"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24066"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.11.1771"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.23789"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/acn3.225"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mito.2010.12.003"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2008.03.019"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2010.07.001"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6770-5"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.analchem.3c00091"}],"container-title":["Movement Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mds.29808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:20:09Z","timestamp":1760959209000},"score":1,"resource":{"primary":{"URL":"https:\/\/movementdisorders.onlinelibrary.wiley.com\/doi\/10.1002\/mds.29808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,2]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10.1002\/mds.29808"],"URL":"https:\/\/doi.org\/10.1002\/mds.29808","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.10.28.23297713","asserted-by":"object"}]},"ISSN":["0885-3185","1531-8257"],"issn-type":[{"value":"0885-3185","type":"print"},{"value":"1531-8257","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,2]]},"assertion":[{"value":"2023-12-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-05-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}